Nifty

:

23907.25

Sensex

:

79117.11

557.35 (2.39%)
1961.32 (2.54%)

Login

Nifty
Sensex

:
:

23907.25
79117.11

557.35 (2.39%)
1961.32 (2.54%)

Accent Microcell Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: Not Listed | NSE: ACCENTMIC

Watchlist

NSE BSE

282.65

05-Jul-2024

Open
High
Low
Previous Close

289.00
290.00
279.00
289.45

Volume
Traded Value (lacs)
52 Week High
52 Week Low

64500
183.19
364.00
224.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

505.77
16.77
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

446.07
0.42%
3.09

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
-

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

-

P:BV (Average)

8 Years
5 Years
3 Years

-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22
Net Sales - 245.50 197.27 165.71 Net Sales Growth - 24.45% 19.05% Cost Of Goods Sold - 145.93 119.48 113.34 Gross Profit - 99.57 77.79 52.37 GP Margin - 40.56% 39.43% 31.60% Total Expenditure - 206.03 178.32 152.74 Power & Fuel Cost - 22.71 23.26 3.34 % Of Sales - 9.25% 11.79% 2.02% Employee Cost - 11.03 8.97 7.62 % Of Sales - 4.49% 4.55% 4.60% Manufacturing Exp. - 11.26 9.63 9.94 % Of Sales - 4.59% 4.88% 6.00% General & Admin Exp. - 2.89 2.77 2.51 % Of Sales - 1.18% 1.40% 1.51% Selling & Distn. Exp. - 9.93 13.78 15.55 % Of Sales - 4.04% 6.99% 9.38% Miscellaneous Exp. - 2.27 0.45 0.43 % Of Sales - 0.92% 0.23% 0.26% EBITDA - 39.47 18.95 12.97 EBITDA Margin - 16.08% 9.61% 7.83% Other Income - 3.63 2.49 1.83 Interest - 1.15 2.53 3.07 Depreciation - 4.43 4.11 4.15 PBT - 37.53 14.80 7.59 Tax - 6.36 2.57 1.70 Tax Rate - 17.41% 17.36% 22.40% PAT - 30.17 12.23 5.89 PAT before Minority Interest - 30.17 12.23 5.89 Minority Interest - 0.00 0.00 0.00 PAT Margin - 12.29% 6.20% 3.55% PAT Growth - 146.69% 107.64% EPS - 14.37 5.82 2.80

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22
Shareholder's Funds 163.83 50.43 32.09 Share Capital 21.04 12.94 12.90 Total Reserves 142.79 37.48 19.19 Non-Current Liabilities 3.15 6.59 8.60 Secured Loans 1.47 2.48 3.24 Unsecured Loans 0.02 2.99 3.70 Long Term Provisions 0.79 0.23 0.42 Current Liabilities 46.47 56.20 53.92 Trade Payables 19.23 34.58 30.10 Other Current Liabilities 7.93 4.14 8.96 Short Term Borrowings 9.91 14.63 14.43 Short Term Provisions 9.40 2.85 0.44 Total Liabilities 213.45 113.22 94.61 Net Block 29.04 31.31 30.12 Gross Block 66.68 63.52 58.53 Accumulated Depreciation 37.64 32.21 28.42 Non Current Assets 41.40 33.02 30.69 Capital Work in Progress 1.86 0.00 0.00 Non Current Investment 0.00 0.00 0.00 Long Term Loans & Adv. 10.50 1.71 0.57 Other Non Current Assets 0.00 0.00 0.00 Current Assets 172.06 80.15 63.92 Current Investments 0.00 0.00 0.00 Inventories 32.98 41.94 39.59 Sundry Debtors 53.80 30.35 17.04 Cash & Bank 72.49 2.05 2.83 Other Current Assets 12.78 2.57 3.98 Short Term Loans & Adv. 10.42 3.24 0.49 Net Current Assets 125.58 23.95 10.00 Total Assets 213.46 113.23 94.61

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22
Cash From Operating Activity 11.33 7.57 14.87 PBT 36.53 14.80 7.59 Adjustment 5.97 6.27 6.75 Changes in Working Capital -24.87 -10.80 2.19 Cash after chg. in Working capital 17.63 10.26 16.53 Interest Paid 0.00 0.00 0.00 Tax Paid -6.08 -2.54 -1.66 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items -0.22 -0.16 0.00 Cash From Investing Activity -82.34 -4.04 -4.30 Net Fixed Assets -5.02 -4.99 Net Investments 0.00 0.00 Others -77.32 0.95 Cash from Financing Activity 72.27 -4.32 -9.67 Net Cash Inflow / Outflow 1.26 -0.79 0.90 Opening Cash & Equivalents 0.31 1.10 0.20 Closing Cash & Equivalent 1.58 0.31 1.10

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22
Book Value (Rs.) 77.86 38.92 8.29 ROA 18.47% 11.77% 6.72% ROE 28.17% 29.67% 20.07% ROCE 30.16% 26.79% 18.78% Fixed Asset Turnover 3.77 3.23 2.93 Receivable days 62.56 43.85 32.66 Inventory Days 55.70 75.42 78.34 Payable days 67.29 98.79 78.01 Cash Conversion Cycle 50.97 20.48 32.99 Total Debt/Equity 0.08 0.45 0.75 Interest Cover 32.88 6.84 3.48

Top Investors:

kantilal pachan vadia

negen undiscovered value fund

Annual Reports:

News Update:

No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback